Cannabis Marketing

Why It’s Time for Cannabis Brands to Think Bigger on 420

Let’s face it—4/20 in Germany right now is mostly… promo codes.You log into your favorite online headshop, you see a “-X% for 4/20” banner, and that’s about it. Compare that to the United States, where brands go all-in: Live DJ sets, Instagram lives with giveaways, Digital scavenger hunts, In-store treasure maps, Influencer challenges, and fully […]

Why It’s Time for Cannabis Brands to Think Bigger on 420 Read More »

GUIDE: Why Every Medical Cannabis Brand Should Launch an Accessory Shop – And How to Start with Just 3 Essentials!

As Germany’s cannabis market professionalizes, more pharmacies and medical brands are realizing: a prescription alone doesn’t build patient loyalty nor brand loyalty!  Modern cannabis patients are discerning, brand-aware, and looking for more than just flowers or oil. They want tools that make their journey easier, safer, and more personal. Two standout brands, Grünhorn and 420FAM,

GUIDE: Why Every Medical Cannabis Brand Should Launch an Accessory Shop – And How to Start with Just 3 Essentials! Read More »

What Cannabis Companies Should Do on 4/20 — And Why It’s the Best Day to Activate Your Brand

April 20th — or “4/20” — isn’t just a date on the calendar.It’s the single most visible day for cannabis culture, patients, brands, and businesses alike. And in Germany’s newly legalized environment, it’s also a massive opportunity. But here’s the catch: 4/20 isn’t about pushing products — it’s about showing up with purpose.Whether you’re a

What Cannabis Companies Should Do on 4/20 — And Why It’s the Best Day to Activate Your Brand Read More »

What Cannabis Founders Can Learn from Starbucks’ New CEO: 3 Key Lessons in Communication

The announcement of Brian Niccol’s move from Chipotle to Starbucks caused a stir in the stock market: Starbucks’ shares soared by over 20%, while Chipotle’s dropped by up to 14%. Under Niccol’s leadership, Chipotle’s revenue doubled, profits increased sevenfold, and the stock price skyrocketed by 800%. This dramatic change underscores the powerful influence a CEO’s

What Cannabis Founders Can Learn from Starbucks’ New CEO: 3 Key Lessons in Communication Read More »

G-BA decision in medical Germany: Evolving Business Models in the Cannabis Industry – Adapting to Regulatory Changes and Market Demands

The recent decision by the German Federal Joint Committee (G-BA) to relax the requirement for prior approval from health insurers for certain medical cannabis prescriptions, expected to take effect in two months, marks a significant shift in the cannabis industry. Should the G-BA’s proposals be approved by the Ministry of Health, an estimated more than

G-BA decision in medical Germany: Evolving Business Models in the Cannabis Industry – Adapting to Regulatory Changes and Market Demands Read More »

The Current Debate and Reforms in Germany’s Pharmacy Coverage

Germany is currently engaged in a critical dialogue about reforming pharmacy services, especially in rural areas affected by widespread personnel shortages. Do you think that this is a chance for the German society, facing those discussions now, rather that later? What would be the downside when it comes to “asking your local pharmacist”, exchanged by

The Current Debate and Reforms in Germany’s Pharmacy Coverage Read More »

Launching a New High-Margin Strain in Germany: Understanding Cannabis Consumer Preferences

Introduction For startups aiming to introduce a new high-margin cannabis strain in Germany, leveraging the influence of popular personalities can be a game-changer. Understanding consumer preferences, consumption patterns, and desired effects is crucial for creating a brand that resonates with the market and achieves high profitability. This article provides key insights and strategies to help

Launching a New High-Margin Strain in Germany: Understanding Cannabis Consumer Preferences Read More »

Balancing Act: Navigating the Ethical and Legal Complexities of Cannabis Marketing in the Pharmaceutical Sector

The discourse surrounding the marketing of pharmaceutical products, particularly cannabis, has taken center stage in the pharmaceutical sector, revealing a complex landscape where legal restrictions, cultural perceptions, and patient needs converge. Co-Founder of  thermidor< Dave Barton’s observations highlight a pivotal point of contention: the audacious, sometimes rule-defying, tactics some companies employ to market their products.

Balancing Act: Navigating the Ethical and Legal Complexities of Cannabis Marketing in the Pharmaceutical Sector Read More »

Scroll to Top